Skip to main content

agilon health, inc.

For the period ended Dec 31, 2025. Filed Feb 25, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 25, 2026

AGL$113.39-0.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Cautionary Language Regarding Forward-Looking Statements

All references in this report to “agilon,” “the Company”, “we,” “us” or “our” mean agilon health, inc., together with its consolidated subsidiaries. Unless the context suggests otherwise, references to “agilon health, inc.” mean the parent company without its subsidiaries.

Cautionary Language Regarding Forward-Looking Statements

Statements in this Annual Report on Form 10-K (the “Report”) that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Some of the forward-looking statements can be identified by the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “shall,” “should,” “would,” “could,” “seeks,” “aims,” “projects,” “is optimistic,” “intends,” “plans,” “estimates,” “anticipates” or the negative versions of these words or other comparable terms. Forward-looking statements include, without limitation, all matters that are not historical facts. They appear in several places throughout this Report and include, without limitation, statements regarding our intentions, beliefs, assumptions or current expectations concerning, among other things, our financial position, results of operations, cash flows, prospects, growth strategies, and the impact of the new CMS LEAD Model (each as defined below).

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be outside our control. Although we believe that we have a reasonable basis for each forward-looking statement contained in this Report, we caution you that forward-looking statements are not guarantees of future performance or outcomes and that actual performance and outcomes, including, without limitation, our actual results of operations, financial condition and liquidity, and the development of the market in which we operate, may differ materially from those made in or suggested by the forward-looking statements contained in this Report. In addition, even if our results of operations, financial condition, and cash flows, and the development of the market in which we operate, are consistent with the forward-looking statements contained in this Report, those results or developments may not be indicative of results or developments in subsequent periods. You are therefore cautioned not to place undue reliance on the forward-looking statements included in this report. A number of important factors, including, without limitation, the risks and uncertainties discussed under “Item 1A, Risk Factors” in this Report, could cause actual results and outcomes to differ materially from those reflected in the forward-looking statements. Furthermore, new risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Report. Factors that could cause actual results and outcomes to differ from those reflected in forward-looking statements include, without limitation:

our history of net losses and the expectation that our expenses will increase in the future;

failure to identify and develop successful new geographies, physician partners and payors, or execute upon our growth initiatives;

success in executing our operating strategies or achieving results consistent with our historical performance;

medical expenses incurred on behalf of our members may exceed revenues we receive;

our ability to maintain and secure additional contracts with Medicare Advantage (“MA”) payors on favorable terms, if at all;

our ability to grow new physician partner relationships sufficient to recover startup costs;

availability of additional capital, on acceptable terms or at all, to support our business in the future;

significant reduction in our membership;

transition to a Total Care Model may be challenging for physician partners;

inaccuracy in estimates of our members’ risk adjustment factors, medical services expense, incurred but not reported claims, and earnings pursuant to payor contracts;

public health crises, such as COVID-19, could adversely affect us;

the impact of restrictive clauses or exclusivity provisions in some of our contracts with physician partners;

our ability to hire and retain qualified personnel;

our ability to realize the full value of our intangible assets;

security breaches, cybersecurity attacks, loss of data and other disruptions to our information systems;

our ability to protect the confidentiality of our know-how and other proprietary and internally developed information;

our reliance on our subsidiaries to perform and fund their operations;

our use of algorithms, artificial intelligence (“AI”), and machine learning in our business and challenges with properly managing the development and use of these technologies;

our reliance on a limited number of key payors;

the limited terms of contracts with our payors and our ability to renew them upon expiration;

our ability to navigate the changing healthcare payor market;

our reliance on our payors, physician partners and other providers to operate our business;

our ability to obtain accurate and complete diagnosis data;

our reliance on third-party software, data, infrastructure and bandwidth;

consolidation and competition in the healthcare industry;

the impact of changes to, and dependence on, federal government healthcare programs;

uncertain or adverse economic and macroeconomic conditions, including a downturn or decrease in government expenditures;

regulation of the healthcare industry and our physician partners’ ability to comply with such laws and regulations;

federal and state investigations, audits and enforcement actions;

repayment obligations arising out of payor audits;

negative publicity regarding the managed healthcare industry generally;

our use, disclosure and processing of personally identifiable information, protected health information (“PHI”), and de-identified data;

failure to obtain or maintain an insurance license, a certificate of authority or an equivalent authorization;

changes in tax laws and regulations, or changes in related judgments or assumptions;

our indebtedness and our potential to incur more debt;

our dependence on our subsidiaries for cash to fund all of our operations and expenses;

provisions in our governing documents;

our ability to achieve a return on investment depends on appreciation in the price of our common stock;

non-compliance with the New York Stock Exchange (“NYSE”) could result in a delisting of our securities;

lawsuits not covered by insurance and securities class action litigation;

sustainability issues;

our stock price may be volatile; and

risks related to management transitions, including the search for a Chief Executive Officer, and our ability to effectively manage leadership changes.

Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.